跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Alpha-1 15%
首页
药物
Alpha-1 15%
Alpha-1 15%
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DNA-binding protein using PPR motif and application thereof
CN 116425883 A
申请人: UNIV KYUSHU NAT UNIV CORP
优先权: 2013
CN
7 件公开
Supplement composition and method of use
US 8536220 B2
申请人: FULGHAM MURRAY
优先权: 2011
US
6 件公开
US 8716330 B2
申请人: FULGHAM MURRAY
优先权: 2013
US
4 件公开
METHODS AND COMPOSITIONS FOR MODULATING FIBRINOGEN
EP 4437109 A4
申请人: UNIV BRITISH COLUMBIA
优先权: 2021
CN
EP
US
WO
4 件公开
Ketol fatty acid derivative and plant growth regulating agents
US 7026489 B2
申请人: SHISEIDO CO LTD
优先权: 2000
US
4 件公开
ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
US 2023142991 A1
申请人: NOVOZYMES AS
优先权: 2020
CN
US
WO
3 件公开
NOVEL IMMUNOCONJUGATES
EP 4661969 A1
申请人: CYTOSPIRE THERAPEUTICS LTD
优先权: 2023
EP
US
WO
3 件公开
Soluble highly branched glucose polymers
US 7612198 B2
申请人: ROQUETTE FRERES
优先权: 2003
CN
US
3 件公开
Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
US 6476064 B1
申请人: ALLERGAN INC
优先权: 2001
US
3 件公开
COMPLEX ZINC AND ALPHA-CHLOROCARBOXYLIC ACID COMPOUNDS FOR TREATING SKIN LESIONS
US 2015141504 A9
申请人: MARDI SHALVA IOSIFOVITCH
优先权: 2011
US
3 件公开
PREBIOTIC FOR TREATING DISORDERS ASSOCIATED WITH DISTURBED COMPOSITION OR FUNCTIONALITY OF THE INTESTINAL MICROBIOME
EP 3846901 B1
申请人: NUTRILEADS B V
优先权: 2018
EP
WO
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈